4,000 heart patients to be tracked in major ablation study

NCT ID NCT07024927

First seen Jun 04, 2026 · Last updated Jun 16, 2026 · Updated 1 time

Summary

This study will follow 4,000 people in China who are getting a procedure called catheter ablation for two types of irregular heartbeats: atrial fibrillation and ventricular tachycardia. The goal is to see how well the procedure works over the long term and how safe it is. Participants will be monitored for at least 12 months after their procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Anzhen Hospital, Capital Medical University

    NOT_YET_RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • No. 2 Anzhen Rd, Chaoyang District, 100029

    RECRUITING

    Beijing, Beijing Municipality, 100029, China

Conditions

Explore the condition pages connected to this study.

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.